NEW YORK, Jan. 2, 2024 /PRNewswire/ Seelos Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare.
Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote FOR All Proxy Proposals At The Special Meeting To Be Held On January 1 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.